Johnson & Johnson Proposes $5.5 Billion Settlement for Talc Lawsuits
Summary
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 69,000 lawsuits alleging its talc-based baby powder caused ovarian cancer, while continuing to deny the claims and having ceased talc powder sales.
Key Points
- Johnson & Johnson proposes to pay up to $5.5 billion to settle around 69,000 lawsuits related to talc-based baby powder and ovarian cancer.
- The company denies that its talc-based products cause cancer and has changed its baby powder formula to cornstarch-based.
- Kenvue, spun off from Johnson & Johnson in 2022, holds liability for baby powder sales outside North America.
- A federal court ruled in favor of Johnson & Johnson stating it is difficult to prove talc causes ovarian cancer directly.
